Multi-target chimaeric VLP as a therapeutic vaccine in a model of colorectal cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Multi-target chimaeric VLP as a therapeutic vaccine in a model of colorectal cancer

Published:2017-08-15 Issue:1 Volume:5 Page:
ISSN:2051-1426
Container-title:Journal for ImmunoTherapy of Cancer
language:en
Short-container-title:j. immunotherapy cancer

Author:

Donaldson Braeden,Al-Barwani Farah,Pelham Simon J.,Young Katie,Ward Vernon K.,Young Sarah L.

Funder

University of Otago

Freemasons New Zealand

Publisher

BMJ

Subject

Cancer Research,Pharmacology,Oncology,Molecular Medicine,Immunology,Immunology and Allergy

Link

http://link.springer.com/content/pdf/10.1186/s40425-017-0270-1.pdf

Reference55 articles.

1. Stewart BW, Wild C. International Agency for Research on Cancer & World Health Organization. World Cancer Report 2014. 2014.

2. Maringe C, et al. Stage at diagnosis and colorectal cancer survival in six high-income countries: a population-based study of patients diagnosed during 2000–2007. Acta Oncol. 2013;52:919–32. doi: 10.3109/0284186X.2013.764008 .

3. Balint JP, et al. Extended evaluation of a phase 1/2 trial on dosing, safety, immunogenicity, and overall survival after immunizations with an advanced-generation Ad5 [E1-, E2b-]-CEA(6D) vaccine in late-stage colorectal cancer. Cancer Immunol Immunother. 2015;64:977–87. doi: 10.1007/s00262-015-1706-4 .

4. Morse MA, et al. Phase I study of alphaviral vector (AVX701) in colorectal cancer patients: comparison of immune responses in stage III and stage IV patients. J Immunother Cancer. 2015;3:1.

5. Duggan MC, et al. A phase I study of recombinant (r) vaccinia-CEA (6D)-TRICOM and rFowlpox-CEA (6D)-TRICOM vaccines with GM-CSF and IFN-α-2b in patients with CEA-expressing carcinomas. Cancer Immunol Immunother. 2016;65:1353–1364.

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biomimetic functionalized metal organic frameworks as multifunctional agents: Paving the way for cancer vaccine advances;Materials Today Bio;2024-08

2. The mast cell-T lymphocyte axis impacts cancer: Friend or foe?;Cancer Letters;2024-04

3. Redefining the battle against colorectal cancer: a comprehensive review of emerging immunotherapies and their clinical efficacy;Frontiers in Immunology;2024-03-12

4. The recent advancements in protein nanoparticles for immunotherapy;Nanoscale;2024

5. Potential Application of Self-Assembled Peptides and Proteins in Breast Cancer and Cervical Cancer;International Journal of Molecular Sciences;2023-12-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3